Market Analysis - Monthly Report - September&October, 2020 - Pharmaceutical
ECHEMI monthly report of Pharmaceutical
in September&October 2020

Azithromycin
https://www.echemi.com/cms/128344.html
Remdesivir
https://www.echemi.com/cms/128345.html
Florfenicol
https://www.echemi.com/cms/128346.html
Oseltamivir Phosphate Product&Shikimic Acid
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
24th Pharma Asia International Exhibition & Conferences to Open in Karachi, Pakistan
-
Pharma Asia 2026: Bringing the Global Pharmaceutical Industry to Pakistan
-
Egyptian Pharmaceutical Market Research
-
CPHI China 2023 | At the Heart of Pharma
-
A Guide Into What the Pharmaceutical Use of Hexamine Is
-
In line with the 8201, Hengrui Pharmaceutical plans the HER2 ADC in this way
-
$50 billion in products were 'returned' to rationalize those blockbuster BD deals
-
Tronsound long-acting IL-36R antibody obtained FDA clinical IND
-
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
-
The FDA accepted Zuranolone's NDA application and granted it priority review rights for the treatment of MDD and PDD
Recommend Reading
-
Butadiene rubber prices fall back to pre-Middle East conflict levels in China
-
Both Supply and Demand Weak, Butadiene Market Downward
-
This Week's Maleic Anhydride Market Continues to Decline in China
-
Market Support Weakens, Acetic Acid Prices Continuously Decline
-
Weak Demand Leads to Decline in Toluene Market
-
Uses and Benefits of Sodium Selenite
-
Premium Global Chemical Sourcing Requests (30 Mar-1Apr, 2026)
-
Applications and Safety of Sodium Dichromate
-
FDA Reopens BHA Review—Why One Preservative Is Becoming a Global Wake-Up Call for Food Additives
-
Premium Global Chemical Sourcing Requests (14 - 18 Mar, 2026)